Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Major Shareholding Notification 2022

Jun 28, 2022

61842_rns_2022-06-28_b1da9c30-16d5-4a68-a3e3-f08c9134bc95.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

==> picture [560 x 100] intentionally omitted <==

28 June,2022

To

BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Exchange Plaza, Towers, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip code: 541540 Scrip code: SOLARA

S. Murali Krishna

Company Secretary & Compliance Officer Solara Active Pharma Sciences Limited 2nd Floor, Admin Block, 27, Vandaloor, Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur Post, Chennai – 600127, Tamil Nadu

Dear Sir/ Madam,

Sub: Disclosure under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011- Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a)(ii)

Further to our intimation dated 01 June,2022 under regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (SAST Regulations), please find enclosed the form as prescribed under Regulation 10(6) of the SAST Regulations setting out the details of inter-se transfer of equity shares of Solara Active Pharma Sciences Limited, from Mr. Arun Kumar Pillai to Devicam Capital LLP, through an off-market transaction.

Kindly take the same on record.

Thanking you,

For Devicam Capital LLP

JYOTHINAGARA Digitally signed by JYOTHINAGARAVYASH VYASHA A SRIRAMAN SRIRAMAN RAMAPRASAD Date: 2022.06.28 RAMAPRASAD 15:52:30 +05'30' Jyothinagaravyasha Sriraman Ramaprasad Designated Partner DPIN:00173696

==> picture [560 x 100] intentionally omitted <==

Disclosures under Regulation 10(6) Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1. Name of the Target Company (TC) Name of the Target Company (TC) Name of the Target Company (TC) Solara Active Pharma Sciences Limited Solara Active Pharma Sciences Limited Solara Active Pharma Sciences Limited
2. Name of the acquirer(s) Devicam Capital LLP
3. Name of the stock exchange where
shares of the TC are listed
BSE Limited (“BSE”)
and
National Stock Exchange of IndiaLimited(“NSE”)
4. Details of the transaction
including rationale,
if
any, for
the
transfer/
acquisition
of
shares
Inter-se transfer of equity shares among the promoter
group through an off-market transaction.
5. Relevant regulation under which the
acquirer is exempted from making
open offer
Regulation 10(1)(a)(ii) of the SAST Regulations
6. Whether
disclosure
of
proposed
acquisition was required to be made
under regulation 10 (5) and if so,
-whether disclosure was made and
whether it was made within the
timeline
specified
under
the
regulations.
-date of filing with the stock
exchange

-Disclosure was made within the timeline
-Disclosure date-01 June,2022
7. Details of acquisition Disclosures
required to be
made under
regulation 10(5)
Whether the
disclosures under
regulation 10(5)
are actually made
a. Name of the transferor /
~~seller~~
Mr. Arun Kumar Pillai Yes
b. Date of acquisition 22June,2022 Yes
c. Number of shares/ voting
rights in respect of the
acquisitions from each
person mentioned in 7(a)
above
Name of person No of
Equity
Shares

Yes
Mr. Arun Kumar
Pillai
15,00,
000
d. Total shares~~proposed to be~~
~~acquired~~/ actually acquired
as a
% of diluted share capital of
TC
4.17% Yes

==> picture [560 x 100] intentionally omitted <==

e. Price at which shares
are~~proposed to~~
~~be acquired~~/ actually
acquired
Rs. 408.90/- (Rupees Four
Hundred and Eight Decimal
Ninety Paise only) per share
aggregating
to
Rs.
61,33,50,000/- (Rupees Sixty-
One Crores Thirty-Three Lakhs
Fifty Thousand Only)
Rs. 408.90/- (Rupees Four
Hundred and Eight Decimal
Ninety Paise only) per share
aggregating
to
Rs.
61,33,50,000/- (Rupees Sixty-
One Crores Thirty-Three Lakhs
Fifty Thousand Only)



Yes



Yes
8. Shareholding details Pre-Transaction Post-Transaction
No.
of
shares
held

% w.r.t
total
shar
e
capit
al of
TC
No. of shares
held
%
w.r.t
total
share
capita
l of TC
A ~~Acquirer/~~Transferee
(i)
Devicam Capital LLP 1,51,546 0.42% 16,51,546 4.59%
B ~~Seller/T~~ransferor
(i) Mr. Arun Kumar Pillai 31,68,463 8.80% 16,68,463 4.64%
() Shareholding of each entity shall be shown separately and then collectively in a group.
The above disclosure shall be signed by the acquirer mentioning date & place. In case, there
is more than one acquirer, the report shall be signed either by all the persons or by a person
duly authorized to do so on behalf of all the acquirers.
Signature:
_
Jyothinagaravyasha Sriraman Ramaprasad
Designated Partner
Devicam Capital LLP
DPIN:00173696
Bengaluru
28 June, 2022*
JYOTHINAGARAV
YASHA SRIRAMAN
RAMAPRASAD
Digitally signed by
JYOTHINAGARAVYASHA
SRIRAMAN RAMAPRASAD
Date: 2022.06.28 15:53:35
+05'30'

(*) Shareholding of each entity shall be shown separately and then collectively in a group. The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers.

JYOTHINAGARAV Digitally signed by JYOTHINAGARAVYASHA YASHA SRIRAMAN SRIRAMAN RAMAPRASAD Date: 2022.06.28 15:53:35 RAMAPRASAD +05'30' Signature: _ Jyothinagaravyasha Sriraman Ramaprasad Designated Partner Devicam Capital LLP DPIN:00173696

Bengaluru 28 June, 2022